RecruitingNCT05926622

Clinical and Radiological Outcomes of Medacta Shoulder System FR

Clinical and Radiological Outcomes of Medacta Shoulder System

Sponsor

Medacta International SA

Enrollment

200 participants

Start Date

Mar 15, 2022

Study Type

OBSERVATIONAL

Conditions

This is a post-marketing surveillance on Medacta Shoulder System

Min Age: 18 Years

Patients older than 18 years
Patient with one of the following diagnosis:
Primary osteoarthritis Secondary osteoarthritis Cuff tear arthropathy; insufficient rotator cuff Acute fracture (\<21d) Rheumatoid or inflammatory arthritis Avascular necrosis Other posttraumatic condition Revision of shoulder arthroplasty

Patients with malignant diseases (at the time of surgery)
Patients with proven or suspect infections (at the time of surgery)
Patients with functional deficits other than dysfunction of the shoulder (at the time of surgery)
Patients with known incompatibility or allergy to products materials (at the time of surgery)

Clinique Générale Annecy

Annecy, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT05926622